KEAPSAKE study of telaglenastat vs placebo plus standard-of-care in 1L KEAP1/NRF2-mutated non-squamous metastatic NSCLC Meeting Abstract
| Authors: | Spigel, D. R.; Akerley, W.; Evangelist, M.; Johnson, M.; Levy, B.; Owonikoko, T.; Paik, P.; Papagiannakopoulos, T.; Reckamp, K.; Akella, L.; Holland, S.; Jenkins, Y.; Kuriakose, E.; Rizvi, N. |
| Abstract Title: | KEAPSAKE study of telaglenastat vs placebo plus standard-of-care in 1L KEAP1/NRF2-mutated non-squamous metastatic NSCLC |
| Meeting Title: | 2021 World Conference on Lung Cancer |
| Keywords: | telaglenastat; glutaminase; keapsake |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2021 Sep 8-14 |
| Meeting Location: | Virtual event |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-10-01 |
| Start Page: | S1099 |
| Language: | English |
| ACCESSION: | WOS:000709606500499 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.08.500 |
| Notes: | Meeting Abstract: P47.07 -- Source: Wos |
